Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@peter_brit Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1415954684003618816.png) @peter_brit Peter Davis

Peter Davis posts on X about $nwbo, core, topics, staff the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1415954684003618816/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1415954684003618816/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX +83%
- X Year XXXXXXX +23%

### Mentions: X [#](/creator/twitter::1415954684003618816/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1415954684003618816/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX -XX%
- X Months XXX +92%
- X Year XXX +32%

### Followers: XXXXX [#](/creator/twitter::1415954684003618816/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1415954684003618816/c:line/m:followers.svg)

- X Week XXXXX +0.42%
- X Month XXXXX +0.70%
- X Months XXXXX +6.80%
- X Year XXXXX +11%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1415954684003618816/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1415954684003618816/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  XXXX%

**Social topic influence**
[$nwbo](/topic/$nwbo) #4, [core](/topic/core) 7.69%, [topics](/topic/topics) 7.69%, [staff](/topic/staff) 7.69%, [decentralized](/topic/decentralized) 7.69%, [health](/topic/health) 7.69%, [food](/topic/food) XXXX%

**Top accounts mentioned or mentioned by**
[@northwestbio](/creator/undefined) [@kasperseninvest](/creator/undefined) [@metacollectiveg](/creator/undefined)
### Top Social Posts
Top posts by engagements in the last XX hours

"#dcvax $nwbo #gbm A heartbreaking update from Matthew Collins: "I am really grateful to my doctor who contacted Novacure to request compassionate use of Optune Tumour Treating Fields (I have a mutation that means I would respond better to treatment). Their response to him was no. I could not simply refuse someone as they have me" This isnt a long update. Ive lost use of my left arm so am having to type with one finger and this update has taken me a month. I also cant think of anything to say as my brain slowly withers but today is my 38th birthday. I fully expect it to be my last. When I was"  
[X Link](https://x.com/peter_brit/status/1995780932138143933)  2025-12-02T09:03Z 1431 followers, 1461 engagements


"#dcvax $nwbo #gbm"  
[X Link](https://x.com/peter_brit/status/1996466956439011462)  2025-12-04T06:29Z 1431 followers, 1621 engagements


"#dcvax $nwbo #gbm Excellent post by Elvisdk : He is why this matters so much for Northwest Biotherapeutics. Advent Bioservices now fully owned by NWBO publicly reposting the MHRAs new Rare Therapies Paper is significant for one core reason: the document describes a regulatory pathway that aligns almost perfectly with DCVax-L. The MHRA is explicitly signalling that advanced personalized therapies for small patient populations should be evaluated under modern flexible frameworksfocusing on clinical relevance patient need and robust analytical comparability rather than traditional large"  
[X Link](https://x.com/peter_brit/status/1994011415821074714)  2025-11-27T11:52Z 1431 followers, 1437 engagements


"#dcvax $nwbo #gbm Joint JPAG & APS Symposium : 'Regulatory Hot Topics' X December 2025 from 09:30am Another upcoming presentation from MHRA staff presenting. Topics for the meeting include."Updates on point-of-care/modular manufacture".(MHRA's modular manufacturing is part of the new decentralized manufacturing framework)"  
[X Link](https://x.com/peter_brit/status/1994661451835887738)  2025-11-29T06:55Z 1431 followers, 1857 engagements


"#dcvax $nwbo #gbm Good to see more pressure being put on the Government in Parliament. Answer due today. Question from Jack Rankin MP "To ask the Secretary of State for Health and Social Care what assessment his Department has made of the potential merits of DCVax-L following its trial at Kings College Hospital""  
[X Link](https://x.com/peter_brit/status/1996466060833198270)  2025-12-04T06:26Z 1432 followers, 1740 engagements


"#dcvax $nwbo #gbm FDA shifts to one-trial approvals setting new standard for drug reviews: Dec. X 2025 The news: Pharma and biotech companies will soon be able to seek drug approvals with just one clinical trial instead of the standard two under upcoming policy changes from FDA chief Marty Makary per STAT. The new one pivotal trial requirement that Makary deemed more practical is meant to help speed up reviews and approvals. Some drug reviewers along with Richard Pazdur the top drug regulator who suddenly announced his retirement this week are concerned the new policy will weaken the agencys"  
[X Link](https://x.com/peter_brit/status/1996825910343844228)  2025-12-05T06:16Z 1432 followers, 3085 engagements


"#dcvax $nwbo #gbm News UK fast track drug approval system risks outsourcing critical judgment XX December 2025 BMJ 2025; XXX doi: (Published XX December 2025)Cite this as: BMJ 2025;391:r2556 A system allowing drugs to be approved in the UK by other trusted regulators such as the US Food and Drug Administration (FDA) is sparking concern among experts. They say the strategy risks lowering evidence standards particularly in light of recent scandals in President Trumps FDA including conflicts of interest among panel members and a revolving door between the pharmaceutical industry and the"  
[X Link](https://x.com/peter_brit/status/1996827255461249353)  2025-12-05T06:21Z 1432 followers, 1072 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@peter_brit Avatar @peter_brit Peter Davis

Peter Davis posts on X about $nwbo, core, topics, staff the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXX -XX%
  • X Month XXXXXX -XX%
  • X Months XXXXXXX +83%
  • X Year XXXXXXX +23%

Mentions: X #

Mentions Line Chart

  • X Week XX -XX%
  • X Month XX -XX%
  • X Months XXX +92%
  • X Year XXX +32%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +0.42%
  • X Month XXXXX +0.70%
  • X Months XXXXX +6.80%
  • X Year XXXXX +11%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence cryptocurrencies XXXX%

Social topic influence $nwbo #4, core 7.69%, topics 7.69%, staff 7.69%, decentralized 7.69%, health 7.69%, food XXXX%

Top accounts mentioned or mentioned by @northwestbio @kasperseninvest @metacollectiveg

Top Social Posts

Top posts by engagements in the last XX hours

"#dcvax $nwbo #gbm A heartbreaking update from Matthew Collins: "I am really grateful to my doctor who contacted Novacure to request compassionate use of Optune Tumour Treating Fields (I have a mutation that means I would respond better to treatment). Their response to him was no. I could not simply refuse someone as they have me" This isnt a long update. Ive lost use of my left arm so am having to type with one finger and this update has taken me a month. I also cant think of anything to say as my brain slowly withers but today is my 38th birthday. I fully expect it to be my last. When I was"
X Link 2025-12-02T09:03Z 1431 followers, 1461 engagements

"#dcvax $nwbo #gbm"
X Link 2025-12-04T06:29Z 1431 followers, 1621 engagements

"#dcvax $nwbo #gbm Excellent post by Elvisdk : He is why this matters so much for Northwest Biotherapeutics. Advent Bioservices now fully owned by NWBO publicly reposting the MHRAs new Rare Therapies Paper is significant for one core reason: the document describes a regulatory pathway that aligns almost perfectly with DCVax-L. The MHRA is explicitly signalling that advanced personalized therapies for small patient populations should be evaluated under modern flexible frameworksfocusing on clinical relevance patient need and robust analytical comparability rather than traditional large"
X Link 2025-11-27T11:52Z 1431 followers, 1437 engagements

"#dcvax $nwbo #gbm Joint JPAG & APS Symposium : 'Regulatory Hot Topics' X December 2025 from 09:30am Another upcoming presentation from MHRA staff presenting. Topics for the meeting include."Updates on point-of-care/modular manufacture".(MHRA's modular manufacturing is part of the new decentralized manufacturing framework)"
X Link 2025-11-29T06:55Z 1431 followers, 1857 engagements

"#dcvax $nwbo #gbm Good to see more pressure being put on the Government in Parliament. Answer due today. Question from Jack Rankin MP "To ask the Secretary of State for Health and Social Care what assessment his Department has made of the potential merits of DCVax-L following its trial at Kings College Hospital""
X Link 2025-12-04T06:26Z 1432 followers, 1740 engagements

"#dcvax $nwbo #gbm FDA shifts to one-trial approvals setting new standard for drug reviews: Dec. X 2025 The news: Pharma and biotech companies will soon be able to seek drug approvals with just one clinical trial instead of the standard two under upcoming policy changes from FDA chief Marty Makary per STAT. The new one pivotal trial requirement that Makary deemed more practical is meant to help speed up reviews and approvals. Some drug reviewers along with Richard Pazdur the top drug regulator who suddenly announced his retirement this week are concerned the new policy will weaken the agencys"
X Link 2025-12-05T06:16Z 1432 followers, 3085 engagements

"#dcvax $nwbo #gbm News UK fast track drug approval system risks outsourcing critical judgment XX December 2025 BMJ 2025; XXX doi: (Published XX December 2025)Cite this as: BMJ 2025;391:r2556 A system allowing drugs to be approved in the UK by other trusted regulators such as the US Food and Drug Administration (FDA) is sparking concern among experts. They say the strategy risks lowering evidence standards particularly in light of recent scandals in President Trumps FDA including conflicts of interest among panel members and a revolving door between the pharmaceutical industry and the"
X Link 2025-12-05T06:21Z 1432 followers, 1072 engagements

@peter_brit
/creator/twitter::peter_brit